naproxen has been researched along with Colorectal Neoplasms in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aboul-Fadl, T; Al-Hamad, SS; Fouad, EA | 1 |
| Madka, V; Mohammed, A; Rao, CV; Yarla, NS | 1 |
| Blackler, RW; Elsheikh, W; Flannigan, KL; Wallace, JL | 1 |
| Chattopadhyay, M; Kashfi, K; Kodela, R; Nath, N; Nesbitt, DE; Velázquez-Martínez, CA | 1 |
| Buyse, M; Farinotti, R; Zrieki, A | 1 |
| Hughes, A; Smith, NI; Wallace, HM | 1 |
1 review(s) available for naproxen and Colorectal Neoplasms
| Article | Year |
|---|---|
Clinically Relevant Anti-Inflammatory Agents for Chemoprevention of Colorectal Cancer: New Perspectives.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Combined Chemotherapy Protocols; Aspirin; Celecoxib; Chemoprevention; Colorectal Neoplasms; Cyclooxygenase 2 Inhibitors; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Naproxen; Neoplasm Recurrence, Local | 2018 |
5 other study(ies) available for naproxen and Colorectal Neoplasms
| Article | Year |
|---|---|
Pharmacokinetic studies of naproxen amides of some amino acid esters with promising colorectal cancer chemopreventive activity.
Topics: Administration, Oral; Amides; Amino Acids; Animals; Anticarcinogenic Agents; Colorectal Neoplasms; Drug Stability; Esters; Humans; Hydrogen-Ion Concentration; Hydrolysis; Injections, Intraperitoneal; Kinetics; Liver; Male; Naproxen; Prodrugs; Rats, Wistar | 2018 |
Enhanced chemopreventive effects of a hydrogen sulfide-releasing anti-inflammatory drug (ATB-346) in experimental colorectal cancer.
Topics: Aberrant Crypt Foci; Animals; Anti-Inflammatory Agents, Non-Steroidal; Azoxymethane; Colon; Colorectal Neoplasms; Dinoprostone; Male; Mice; Naproxen; Protective Agents; Rats; Thromboxane B2 | 2014 |
Hydrogen sulfide-releasing naproxen suppresses colon cancer cell growth and inhibits NF-κB signaling.
Topics: Animals; Anticarcinogenic Agents; Apoptosis; Cell Cycle; Cell Proliferation; Colorectal Neoplasms; Dose-Response Relationship, Drug; HT29 Cells; Humans; Hydrogen Sulfide; Male; Mice, Nude; Naproxen; NF-kappa B; Signal Transduction; Thioredoxin-Disulfide Reductase; Time Factors; Tumor Burden; Xenograft Model Antitumor Assays | 2015 |
Cyclooxygenase inhibitors down regulate P-glycoprotein in human colorectal Caco-2 cell line.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Caco-2 Cells; Celecoxib; Colorectal Neoplasms; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Down-Regulation; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Indomethacin; Naproxen; Neoplasm Proteins; Pyrazoles; Reproducibility of Results; RNA, Messenger; Sulfonamides; Time Factors | 2008 |
Polyamines reverse non-steroidal anti-inflammatory drug-induced toxicity in human colorectal cancer cells.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Cell Division; Cell Membrane; Cell Survival; Colorectal Neoplasms; DNA Fragmentation; Dose-Response Relationship, Drug; Fluorescent Dyes; Humans; Indoles; Intercalating Agents; Naproxen; Polyamines; Putrescine; Salicylates; Spermidine; Spermine; Sulindac; Tumor Cells, Cultured | 2003 |